Psilocybin News NZ and Worldwide

Its been awhile, and please excuse us for not sending out our regular campaigns and info!

Life, opportunities and health can all come at you and change so fast!

 

So enjoy this big newsletter - with the latest articles, a request to be involved in one of The New Zealand Herald's next Psilocybin stories and an invitation to be a part of the worlds first ever 24hr micro-dose sit-in!

 

Katie Harris from The NZ Herald is working on a story regarding the number of charges police have laid against people for drug offences in relation to psilocybin.

If you have or someone you know has been charged over psilocybin that may be interested in sharing their story with Katie - contact us to pass along your information or to request her contact details!

 

Join with people around the world for the worlds first ever 24hr micro-dose sit-in!

https://www.eventbrite.com/e/the-worlds-first-24-hr-micro-dose-mushroom-sit-in-tickets-446242582577

Entheo Society of Washington began this journey in downtown Seattle in early October this year, join entheosocietywa.org as they blossom into an international organization and launch their new website -entheosociety.net (coming soon).

 

First-of-its-kind psilocybin trial approved in Vancouver: While the two-month trial will include psychiatric oversight, it's the first of its kind to allow participants to consume a psilocybin drug product at home alone.

Severe depression eased by single dose of synthetic ‘magic mushroom’: A single dose of a synthetic version of the mind-altering component of magic mushrooms, psilocybin, improved depression in people with a treatment-resistant form of the disease, a new study found.

What we know so far about microdosing psychedelics: There is evidence that microdosing leads to brain changes. One study, investigating microdoses of LSD, found altered connectivity across the brain’s limbic system that was associated with changes in mood.

It’s legal to use psilocybin, or ‘magic mushrooms,’ in Oregon. But that could soon change: In 2020, Oregon became the first US state to legalize psilocybin for personal use for those over age 21.

 

First-of-its-kind psilocybin trial approved in Vancouver

A Vancouver-based pharmaceutical company will run the first take-home psilocybin clinical trial in North America.

Severe depression eased by single dose of synthetic 'magic mushroom' | CNN

A single dose of a synthetic version of the mind-altering component of magic mushrooms, psilocybin, improved depression in people with a treatment-resistant form of the disease, a new study found. The randomized, double-blind clinical trial, which authors called "the largest of its kind," compared results of a 25-milligram dose to a 10-milligram and 1-milligram dose of a synthetic psilocybin, COMP360, that was administered in the presence of trained therapists.

What we know so far about microdosing psychedelics

360Info is an open access global information agency of journalists working with academics to address the world's biggest challenges and offer practical solutions Health & Science Taking small quantities of psychedelics over time might improve your mood but there's a lot we don't understand, says Vince Polito in part two of a series on psychedelics and mental health.

It's legal to use psilocybin, or 'magic mushrooms,' in Oregon. But that could soon change | CNN

First came Chrissi DelaCruz's tough breakup with her boyfriend of nine years. Then, her sister died. The pain and loss led DelaCruz to traditional talk therapy. She also relied on alcohol. But nothing really worked. "I was feeling pretty sad and lonely and disconnected and was feeling pretty lost and hopeless in what I needed to do next in my life," the 37-year-old told CNN.

Follow Us
Follow on Facebook
Follow on Instagram
Check out our site  
This email was created with Wix.‌ Discover More